Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Computer model could make eye surgery more precise

NCT ID NCT05551715

Knowledge-focused Sponsor: Vissum, Instituto Oftalmológico de Alicante Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study tested a virtual eye model system (VEMoS) to help personalize cataract and refractive surgery. Researchers collected eye measurements from over 500 participants, including those having surgery and those with healthy eyes. The goal was to find which measurements best predict good vision after surgery, so future surgeries can be tailored to each patient.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Software (Virtual Eye Model System - VEMoS)
What this could lead to
If successful, this could lead to more personalized and accurate refractive or cataract surgeries, improving visual outcomes for patients.
What could go wrong
This is an observational study to validate software, not a treatment trial. The software may not improve outcomes in practice, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

547 people

The number who actually took part.

Started

Apr 2022

Finished

Jan 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For the untreated eyes arm, the inclusion criterion is: • patients from 18 to 40 years of age and with less than 2 D of astigmatism. For the refractive surgery arm, the inclusion criteria are: * for LASIK: sphere between -10 D and +4 D and with less than 3 D of astigmatism. * for SMILE: sphere between -10 D and -3 D, with less than 3 D of astigmatism. For the cataract surgery arm, the inclusion criterion is: • patients older than 50 years old without any active ocular pathologies affecting visual capabilities except cataract and with less than 1 D of astigmatism. Exclusion Criteria: For the untreated eyes and the refractive surgery arms, the exclusion criteria are: * ocular pathology affecting visual capabilities, * reduced transparency of ocular media, * systemic disease affecting visual capabilities. For the cataract surgery arms, the exclusion criterion is: * Systemic disease affecting visual capabilities. * Ocular pathology affecting visual capabilities other than cataract * Included patients will be excluded if surgical complications occurs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cataract are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cataract hyperopia myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Individualized refractive surgery

Contacts and locations

Locations

  • Alicante Vissum Miranza

    Alicante, Alicante, 03016, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.